CRISPR/Cas9 genome editing to treat sickle cell disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Manylion Llyfryddiaeth
Prif Awdur: Ullah, Mohammad
Awduron Eraill: Islam, Farzana
Fformat: Traethawd Ymchwil
Iaith:English
Cyhoeddwyd: Brac University 2023
Pynciau:
Mynediad Ar-lein:http://hdl.handle.net/10361/19355